Hepalink Pharma IPO Initiation: Take a Chance on Me
Shenzhen Hepalink Pharma Co., Ltd. (002399 CH) is a leading China-based pharmaceutical company with global businesses in pharmaceutical, innovative...
711 Views
Trade Idea (Update): What's Next After HSCI Review Announcement
After the market close on Feb 21st, Friday, Hang Seng announced the results of the index review for the 4Q2019. In our previous note (link here),...
349 Views
Trade Idea: Buy the Candidates Of HSCI Review and HK Connect
We expect Hang Seng to announce the half-year review on Friday, Feb 21st, which will provide a list of stocks to be eligible for the inclusion into...
436 Views
Hong Kong Buyback Weekly: Fosun Intl, Link REIT, Viva Biotech
Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...
308 Views
Long Pharmaron/Short Wuxi: Take Profit Now, A-Share Pullback the Key Risk
Pharmaron, the second-largest contract research organization (CRO) in China, was listed in Hong Kong on November 28th. The deal was anchored by a...
434 Views